SCHEMBL7355113

SCHEMBL7355113

O=c1oc2ccccc2c(O)c1C(c1ccccc1)c1ccccc1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 10/20 0.94
TOP1 P11387 1/20 0.85
CYP2C9 P11712 2/20 0.74
CRHBP P24387 1/20 0.74
CASP7 P55210 1/20 0.74
CASP6 P55212 1/20 0.74
CRHR2 Q13324 1/20 0.74
HIF1A Q16665 1/20 0.74
VKORC1 Q9BQB6 1/20 0.73
TOP2A P11388 1/20 0.71
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
KDM4E B2RXH2 1/20 0.68
ALDH1A1 P00352 1/20 0.68
LMNA P02545 1/20 0.68
POLB P06746 1/20 0.68
MAPT P10636 1/20 0.68
RECQL P46063 1/20 0.68
GALK1 P51570 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7896856 0.97 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL4385323 0.92 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL28156470 0.89 NQO1 (0.75) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL14172083 0.88 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL28157217 0.87 NQO1 (0.71) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL18126686 0.86 NQO1 (0.78) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL1649097 0.86 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL12028810 0.85 NQO1 (0.86) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL7355322 0.85 VKORC1 (0.74) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL4390609 0.85 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP claimed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US claimed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP claimed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO claimed
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP disclosed
US-6169181-B1 HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY 2001-01-02 US disclosed
US-5852195-A Pyranone compounds useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1998-12-22 US disclosed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US disclosed
EP-0758327-A1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1997-02-19 EP disclosed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP disclosed
WO-1995030670-A2 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-16 WO disclosed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO disclosed